TABLE 2

Secondary end-points

Baseline1 month3 monthsChange from baseline to 3 monthsp-value (Friedman's test)
Cough severity VASMedian 31.0 (9, 94)23.0 (3, 88)19.0 (0, 62)−11.0 (−93, 20)0.003
Mean 39.8 (26.8)33.6 (25.2)19.8 (17.7)−19.3 (27.0)
Cough urge VASMedian 26.0 (8, 94)26.0 (2, 83)19.0 (0, 61)−7.0 (−83, 42)0.163
Mean 37.7 (24.9)32.8 (23.1)22.2 (18.4)−14.5 (28.3)
LCQMedian 15.96 (5.07, 19.74)17.6 (6.11, 20.75)19.02 (14.93, 20.38)1.85 (−1.17, 12.18)0.006
Mean 14.63 (4.07)16.68 (3.41)18.23 (1.76)3.47 (4.0)
KSQ_GHMedian 50.7 (23.8, 100)61.9 (29.4, 100)72.25 (39.9, 100)16.3 (−13.8, 47.1)0.001
Mean 53.2 (18.3)63.0 (18.1)69.63 (15.4)17.2 (15.7)
KSQ_lungMedian 50.2 (29.0, 68.0)52.6 (33.6, 77.1)61.95 (41.6, 100)6.5 (−1.3, 34.8)0.001
Mean 52.0 (10.4)54.5 (12.0)62.5 (14.0)10.7 (11.3)
KSQ_lung_GHMedian 58.1 (36.7, 74.7)58.7 (41.9, 86.1)66.25 (50.1, 91.5)10.7 (−2.3, 26.8)0.001
Mean 57.3 (9.1)61.9 (11.6)67.58 (10.4)10.6 (8.3)

Data are presented as median (range) and mean (sd). VAS: visual analogue scale; LCQ: Leicester cough questionnaire; KSQ: King's sarcoidosis questionnaire (presented as general health (GH), lung and combined lung-GH domains).